Myofascial Trigger Point Pain

Myofascial Trigger Point Pain is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Myofascial Pain Dysfunction Syndrome · Myofascial Pain Syndromes · Myofacial Pain · Myofascial Pain Syndrome · Myofascial Pain
Classified under: Musculoskeletal and Connective Tissue Diseases
Nervous System Diseases
Physiological and Biological Processes
Signs, Symptoms, and General Pathologies
Indicated drugs: Botulinum toxin type A
Nortriptyline

Resolves to

Vocabularies

MeSHM0014349ICD-10M79.1SNOMED CT1304004MedDRA10016631UMLSC0016053

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

97Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Myofascial Trigger Point Pain share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.